Social Media Ideas for Aacr

The AACR Rare Cancers Initiative: Uniting Researchers, Undoing Barriers, and Unleashing Progress

At the recent AACR Special Conference on Breaking Barriers in the Fight Against Rare Cancers, AACR Immediate Past President Lillian L. Siu, MD, FAACR, announced the AACR Rare Cance...

Breaking News: Daraxonrasib Approved for Pancreatic Cancer

Today, the U.S. Food and Drug Administration approved daraxonrasib (Rasonque), a groundbreaking new drug for pancreatic cancer that targets the RAS family of proteins. Catch up on...

AACR D3 Offered a Peek Into the Cancer Drug Pipeline, Innovative AI Tools, and More

We highlight some of the many innovations showcased at the inaugural AACR Drug Discovery and Development (AACR D3) conference, including investigational KRAS degraders, approaches...

Inaugural AACR D3 Opens With Insights From Leaders Across Drug Discovery and Development

During the opening session of the AACR Conference on Drug Discovery and Development, the conference cochairs—Patricia M. LoRusso, DO, PhD (hc), FAACR; Keith T. Flaherty MD, FAACR;...

AACR in the News: Cancer Disparities Progress Report and OMB Statement

A variety of national and local news outlets have highlighted AACR initiatives and experts in recent weeks. Learn about the news stories covering the findings from the AACR Cancer...

From the Bench, AACR D3 2026: Emerging Therapeutic Strategies to Inhibit KRAS, Enhance ADCs, and Tackle Resistance

The AACR D3 edition of “From the Bench” highlights cutting-edge approaches from the meeting that could shape the next generation of cancer treatments. We spoke with Andrea Wang-Gil...

Catching the Drift: How Wildfire Smoke Plumes May Increase Cancer Risk

Exposure to wildfire smoke may increase the risk of developing several cancers, according to research presented at the AACR Annual Meeting 2026 by Shuguang Leng, MBBS, PhD, and Qiz...

Smart Chemotherapy Gets Smarter: Advances in Antibody-drug Conjugates

Antibody-drug conjugates, or ADCs, have emerged as a significant class of cancer therapies over the past two decades. New research has helped to revolutionize the drug class and de...

World Cancer Research Fund

www.wcrf.org Twitter: @WCRF_UK and @wcrfint Primary research areas Cancer Grant types Early Career Fellowship, Clinical Study, Programme, Project (typically <4 years) Rese...

Harmonizing Data Collection for Precision Oncology: AACR Project GENIE® Data Model

The AACR Project GENIE Data Model, recently released by the AACR GENIE consortium, is an open-access tool designed to help simplify data harmonization in precision oncology. Learn...

Arcus: 'Buy' On Casdatifan Late-Stage CcRCC Advancement And 1st-Line Expansions

Editors’ Picks, July 2026: AI-powered Pancreatic Proteomics, Sex-based Immune Differences, and More

In July, the editors from AACR's 10 peer-reviewed journals highlighted research on AI-driven molecular mapping of pancreatic cancer evolution, sex differences in immune responses,...

Against Breast Cancer

www.againstbreastcancer.org.uk Facebook:https://www.facebook.com/againstbc/ LinkedIn: https://www.linkedin.com/company/against-breast-cancer Instagram: @againstbreastcancer1 Pi...

Action for A-T

http://www.actionforat.org/ Twitter: @actionforAT Primary research areas Neurological Additional research areas Cancer, Respiratory, Inflammatory and i...

What Are Antibody-drug Conjugates?

Antibody-drug conjugates, or ADCs, are increasingly common cancer therapies. But what are they? How do they work? And how were they discovered? Learn about the history of ADCs, the...

Editors’ Picks, August 2026: Weight Loss and Breast Cancer Biomarkers, Predicting Early-onset Cancer Cases, and More

The August 2026 Editors’ Picks from AACR journals cover the impact of weight loss and omega-3 supplementation on breast cancer risk, early-onset cancer prediction, and more. The...

Driving CAR T-cell Therapy in New Directions

Featuring insights from Carl H. June, MD, FAACR, this post covers the ongoing challenges facing CAR T-cell therapy and some of the latest approaches that strive to overcome these h...

Cancer Research UK

www.cancerresearchuk.org Twitter: @CR_UK Primary research areas Cancer Grant types Clinical trial, Early Career Fellowship, Mid Career Fellowship, Senior Fellowship, Travel an...

Unboxing Cancer News, August 2026: Fishy Cancer, Federal- vs. Industry-funded Trials, and More  

Cancer Research Catalyst has launched a new monthly series, “Unboxing Cancer News,” that highlights exciting cancer research discoveries. Read the first installment and learn about...

Target Ovarian Cancer

www.targetovariancancer.org.uk Twitter: @TargetOvarian Primary research areas Cancer Grant types Project (typically <4 years) Research stage Translational research How t...

From Treatment to Prevention: How Vaccines Are Reshaping the Fight Against Pancreatic Cancer

Cancer immunology expert and former AACR president Elizabeth Jaffee, MD, FAACR, discusses the latest progress in the research on pancreatic cancer vaccines and explains why cancer...

Daraxonrasib shows early antitumor activity in RAS-mutant lung cancer

Daraxonrasib, Revolution Medicines tarafından geliştirilen deneysel bir oral RAS inhibitörü, ameliyat dışı NSCLC olgularının yaklaşık üçte birini oluşturan ve PD-1 ek...

AcademyHealth Releases Strategic Roadmap for Advancing Cancer Biomarker Testing at Scale

AcademyHealth Releases Strategic Roadmap for Advancing Cancer Biomarker Testing at Scale For patients facing uncertainty or fear around a cancer diagnosis, cancer biomarker...

Friends of EORTC

http://www.eortc.org Primary research areas Cancer Grant types Clinical Trial, Clinical Study, Research Centre, Fellowship, Project (typically <4 years), Infrastructure Res...